Inventor
THOMAS T. NGUYEN
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes24%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
12,540,129KIF18A inhibitors202612,459,932KIF18A inhibitors202512,440,491KRAS G12C inhibitors and methods of using the same202512,441,736KIF18A inhibitors202512,435,058KIF18A inhibitors202512,083,121Substituted piperazines as KRAS G12C inhibitors202411,905,281KRAS G12C inhibitors and methods of using the same202411,766,436KRAS G12C inhibitors and methods of using the same202311,285,156Substituted piperazines as KRAS G12C inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to AMGEN INC (9)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 9 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |